Rheumatologic Adverse Events and Cancer Immunotherapy

Poitiers University Hospital

Status: Unknown

Conditions: Adverse Drug Event; Oncology; Arthritis; Autoimmunity

Treatments: Other: Fill in a form

Study type: Interventional

Funder types: Other

Identifiers

NCT04791150

ONCOIMMUNO

Details and patient eligibility

About

In this study, every patient with cancer who is going to be treated by immunotherapy will fill in a form. In this form, we try to determine if he presents rheumatologic complications of his immunotherapy. If the patient answers yes to one question on the form, the patient will be see in rheumatologic consultation to explore his clinical signs.

The number of patients referred in consultation thanks to this questionnaire will be compared to the number of patients who would have been spontaneously referred by the oncologist.

The aim of this questionnaire is to optimise the management of rheumatological effects secondary to immunotherapy.

Enrollment: 400 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with cancer needed to be treated by immunotherapy

Exclusion criteria

• Patient already treated by immunotherapy

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

400 participants in 1 patient group

Patient with cancer immunotherapy treatment

Experimental group

Description:

All patients starting immunotherapy treatment will complete a questionnaire to identify rheumatological side effects, each time they come for treatment.

Treatment:

Other: Fill in a form